Skip to main content
Publications
Hood K, Bensink M, Ayoub I, Peipert JD, Trachtman H, Wadhwani S, Garbinsky D, Wang J, Zhou X, Bennett L, Choi J, Gong W, Inrig JK, Komers R. Patient-reported outcomes in rare kidney disease clinical trials: sparsentan versus irbesartan. Poster presented at the American Nephrology Nurses Association (ANNA) National Symposium; May 1, 2025. Portland, OR.
Wadhwani S, Bensink M, Peipert JD, Ayoub I, Preciado P, Garbinsky D, Wang J, Choi J, Bennett L, Gong W, Inrig J, Komers R. Patient-reported outcomes in the PROTECT clinical trial comparing sparsentan with irbesartan for IgA nephropathy. Poster presented at the American Society of Nephrology (ASN) Kidney Week 2024; October 23, 2024. San Diego, CA. [abstract] J Am Soc Nephrol. 2024 Oct; 35(Suppl v1):723.
Toback S, Hollis K, Beyhaghi H, Ziemiecki R, Odom D, Choi JM, Layton JB, Odak S, Jackson L, Williams V, Marchese AM, Milller A, Rousculp M. Presenteeism: the reality to be discussed with COVID-19 vaccine recipients. Poster presented at the European Scientific Working Group on Influenza (ESWI); September 17, 2023. Valencia, Spain.
Rousculp M, Beyhaghi H, Hollis K, Ziemiecki R, Layton JB, Odak S, Jackson L, Odom D, Williams V, Choi JM, Montazeri M, Marchese AM, Toback S. Burden and impact of reactogenicity among United States and Canadian adults receiving COVID-19 vaccines: Vaccine Impact on Productivity (VIP) Study. Poster presented at the European Scientific Working Group on Influenza (ESWI); September 17, 2023. Valencia, Spain.